Risk factors of multi-drug-resistant tuberculosis in Bangladeshi population: A case control study

Bangladesh Medical Research Council Bulletin

Volumn 39, Issue 1, 2013, Pages 34-41

  Flora, M S ^a   Amin, M N ^b   Karim, M R ^a   Afroz, S ^c   Islam, S ^d   Alam, A ^a   Hossain, M ^b  

^a National Institute of Preventive and Social Medicine   (Bangladesh)

^b Department of Medicine Combined Military Hospital (CMH)   (Bangladesh)

^c Northern International Medical College   (Bangladesh)

^d RESEARCH AND EVALUATION DIVISION   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; BANGLADESH; CASE CONTROL STUDY; CONTROLLED STUDY; EXPOSURE VARIABLE; HUMAN; INTERVIEW; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME VARIABLE; RISK FACTOR; SOCIAL STATUS; SPUTUM;

EID: 84880871943     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v39i1.15808     Document Type: Article

References (29)

1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1-8.
2. WHO. WHO Report 2007. Global Tuberculosis Control. Surveillance, Planning, Financing. World Health Organization Switzerland: 2007.
3. WHO. Drug and multi drug-resistant tuberculosis (MDR-TB). Frequently asked questions. http://www.who.int/tb/challenges/mdr/faqs [accessed on Apr14, 2008].
4. WHO. Stop TB Partnership. The global MDR-TB and XDR-TB response plan 2007-2008. http://www.who.int [accessed on Apr 02, 2008
5. SAARC Tuberculosis Center. Tuberculosis in the SAARC Region-an update. Kathmandu, Nepal, SAARC Tuberculosis Center: 2009.
6. Anonymous. Estimates of numbers of individuals with MDR TB. British Medical Bulletin. 73-74(1):17-24.
7. NTP. National Tuberculosis Control in Bangladesh. Annual Report 2007. National Tuberculosis Control Programme, DGHS, MOH&FW. Dhaka: 2008.
8. WHO. Communicable Diseases, Tuberculosis. TB in South- East- Asia, Country profile-Bangladesh 2009.
9. http://nasmis.dghs.gov.bd/dghs-new/dmdocuments/Bangladesh.pdf. [Accessed on Dec 27, 2011
10. NTP. National Guidelines and Operational Manual for Tuberculosis Control. 4th Edition. National Tuberculosis Control Programme, DGHS, MOH&FW. Dhaka: 2009.
11. Diandé S, Sangaré L, Kouanda S and et al. Risk factors for multi-drug-resistant tuberculosis in four centers in Burkina Faso, West Africa. Microb Drug Resist 2009; 15:217-21.
12. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61:158-63. doi: 10.1136/thx.2005.045963)
13. Biswas MS. Acknowledgement. In: NTP, DGHS. Tuberculosis Control in Bangladesh, TB Annual Report 2007. Dhaka.
14. Wahab F, Ashraf S, Khan N, Anwar R, Afridi MZ. Risk factors for multidrug-resistant tuberculosis in patients at tertiary care hospital, Peshwar. J Coll Physicians Surg Pak 2009; 19: 162- 4.
15. Suarez GI, Rosriquez BA, Vidal- Perez JL and et al. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis 2009; 28: 325- 30.
16. Law WS, Yew WW, Chiu LC, Kam KM, Chan CK, Leung CC. Risk factors for multidrug- resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2008; 12: 1065-70.
17. Franke MF, Appleton SC, Bayona J and et al. Risk Factors and Mortality Associated with Default from Multidrug- Resistant Tuberculosis Treatment. Clin Infect Dis 2008; 46: 1844- 51.
18. Espinal MA, Laserson K, Camacho M and et al. determinants of drug- resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887- 93.
19. Anunnatsir S, Chetchotisakd P, Wanke C. Factors Associated with Treatment outcomes in Pulmonary Tuberculosis in Northeastern Thailand. Southeast Asian J Trop Med Public Health 2005; 36: 324-30.
20. Rahman MA, Hussain MW, Alam F, Jahan MS. Multidrug Resistant Tuberculosis: Experience in Bogra. Journal of Teachers' Association RMC 2005; 18: 30-6.
21. Amin MN, Rahman MA, Flora MS, Azad MAK. Factors associated with multidrug-resistant tuberculosis. Ibrahim Med Coll J 2009, 3(1): 29-33.
22. Anderson LF, Laurenson IF, Blatchford O, Shakir E, McMenamin J, Johnston F. Trends in Multidrugresistant Tuberculosis in Scotland, 2000-7. Eurosurveillance Reports, Vol. 14, Issue 11; 19 March 2009.
23. Baghaei P, Tabarsi P, Chitsaz E and et al. Risk Factors Associated with Multidrug- esistant Tuberculosis. National Research Institute of Tuberculosis and Lung Disease, Iran. Tanaffos (2009) 8 (3), 17- 21.
24. Banu S, Hossain A, Uddin MKF and et al. Pulmonary tuberculosis and drug resistance in Dhaka Central Jail, the prison in Bangladesh. PLoS One 2010; 5: e10759.
25. Lomtadze N, Aspindzelashvili R, Jangava M and et al. Prevalence and Risk factors for Multidrug-Resistant Tuberculosis in Republic of Georgia: A population Based Study. Int J Tuberc Lung Dis 2009; 13: 68- 73.
26. Kodmon C, Niemann S, Lukacs J, Sor E, David S, Somoskovi A. Molecular Epidemiology of Drug- Resistant Tuberculosis in Hungary. J Clin Microbiol 2006; 44: 4258-61.
27. Freiden TR, Khatri GR. Multidrug-Resistant Tuberculosis. In: Narain JP, editor. Tuberculosis Epidemiology and Control. WHO, Regional Office for South East Asia, New Delhi: 2002.
28. TB policy in Bangladesh 2006. http://www.Soros.org/health/article- publication [accessed on Apr14, 2008].
29. Khalequzzaman M, Younus M, Rahim J and et al. Epidemiology and surveillance of multidrug- resistant tuberculosis in urban and rural areas of Bangladesh. http://www.icddrb.org/pub/publication [accessed on Mar 24, 2008].